{"result": "(\"entity\"<|>GLUCAGON TEST<|>EVENT<|>The glucagon test is a medical procedure used to assess the body's response to glucagon, particularly in relation to blood sugar levels.)\n##\n(\"entity\"<|>GLYCOGENOSIS<|>EVENT<|>Glycogenosis refers to a group of inherited metabolic disorders characterized by the abnormal storage of glycogen in the body, affecting various organs and systems.)\n##\n(\"entity\"<|>VON GIERKE<|>PERSON<|>Von Gierke is a historical figure known for describing Glycogenosis type I in 1929, which is a metabolic disorder affecting glycogen storage.)\n##\n(\"entity\"<|>GLUCOSE-6-PHOSPHATASE<|>ORGANIZATION<|>Glucose-6-phosphatase is an enzyme critical for glucose metabolism, particularly in the liver, and is associated with Glycogenosis type I.)\n##\n(\"entity\"<|>GLYCOGEN<|>ORGANIZATION<|>Glycogen is a stored form of glucose in the body, primarily found in the liver and muscles, and is involved in energy metabolism.)\n##\n(\"relationship\"<|>VON GIERKE<|>GLYCOGENOSIS<|>Von Gierke described Glycogenosis type I, linking his name to this specific metabolic disorder<|>8)\n##\n(\"relationship\"<|>GLYCOGENOSIS<|>GLUCAGON TEST<|>The glucagon test is relevant in diagnosing and understanding the effects of glycogen storage diseases like Glycogenosis<|>6)\n##\n(\"relationship\"<|>GLUCOSE-6-PHOSPHATASE<|>GLYCOGENOSIS<|>Glucose-6-phosphatase deficiency is a key factor in Glycogenosis type I, making it a critical enzyme in this condition<|>9)\n##\n(\"relationship\"<|>GLYCOGEN<|>GLYCOGENOSIS<|>Glycogenosis involves abnormal glycogen storage, indicating a direct relationship between the two<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ades ocasio-                           test de glucagón, la respuesta de la glucemia es escasa\nnadas por una alteración en la síntesis (glucogénesis) o                    o nula y puede aumentar la acidosis láctica en el caso\nen la degradación (glucogenólisis) del glucógeno o en                       de la glucogenosis de tipo I, pudiendo diferir en otras.\nla glucólisis, que tienen como consecuencia un acúmu-                       La administración de galactosa o fructosa no mejora la\nlo tisular de glucógeno de características normales                         hipoglucemia y puede empeorar la acidosis.\npero en cantidad excesiva, un glucógeno anómalo o                             Para asegurar el diagnóstico de la glucogenosis de\nbien una ausencia en su producción.                                         tipo I, en primer lugar se estudiará el gen de transloca-\n   Las glucogenosis se clasifican en tres grupos según                      sa de la glucosa-6-fosfato (Ib); en el caso de que fuese\npredomine la afectación hepática, muscular o sistémi-                       normal, se pasará a estudiar el gen de la subunidad\nca (tabla 8). Las glucogenosis hepáticas son las que                        catalítica de la glucosa-6-fosfatasa (Ia) y si se dieran\ntienen más interés desde el punto de vista nutricional                      mutaciones de interés se obtendría el diagnóstico;\ndebido a que el soporte nutricional adecuado mejora                         pero, si no las hubiera, se pasaría a estudiar la actividad\nsu evolución.                                                               enzimática de la glucosa-6-fosfatasa en una biopsia de\n   Los distintos tipos de glucogenosis se designan con                      tejido hepático29-33.\nnúmeros según el momento de su descripción, la enzi-                          Si el paciente no tiene estudios genéticos realizados,\nma afectada y el nombre de su descubridor (tabla 8).                        el diagnóstico definitivo de la enfermedad de Von Gier-\nAsí, la glucogenosis de tipo I fue la primera descrita, en                  ke lo marca la actividad de la glucosa-6-fosfatasa y la\n1929, por von Gierke.                                                       existencia de glucógeno almacenado en el hígado en-\n   Las glucogenosis son enfermedades con herencia                           contrado por análisis bioquímico y microscópico de la\nautosómica recesiva, exceptuando IXa, déficit de fosfo-                     biopsia de hígado34.\nglicerato quinasa (PGK) y IIb (enfermedad de Danon),                          Además del control metabólico, se precisan revisio-\nque tienen herencia ligada al cromosoma X.                                  nes por Digestivo por la hepatopatía asociada. Otros\n---\n 318      BLOQUE: PROTEÍNAS Y AMINOÁCIDOS\n\n\n\nTabla 8.    Glucogenosis: tipos y enzimas afectadas.\n\n\n\n         Tipo                Defecto enzimático o            Tejido principal           Principales síntomas clínicos\n                                   transportador                 implicado\n\n\n\n  GLUCOGENOSIS HEPÁTICAS\n  Ia                      Glucosa-6-fosfatasa            Hígado, riñón           Hepatomegalia, baja estatura,\n  Von Gierke                                                                     hipoglucemia, hiperlactacidemia,\n                                                                                 hiperlipemia\n  Ib                      Glucosa-6-fosfato              Hígado, riñón,          Igual que Ia y neutropenia e infecciones\n                          translocasa                    leucocitos\n  III                     Enzima desramificante y        Hígado, músculo         Hepatomegalia, cardiopatía y miopatía,\n  Cori, Forbes            subtipos                                               baja estatura, hipoglucemia\n  IV                      Enzima ramificante             Hígado                  Hepatoesplenomegalia, cirrosis\n  Andersen                                                                       hepática, formas neuromusculares raras\n  VI                      Fosforilasa hepática           Hígado                  Hepatomegalia, baja estatura e\n  Hers                                                                           hipoglucemia\n  IX                      Fosforilasa cinasa y           Hígado y/o músculo      Hepatomegalia, baja estatura (miopatía)\n                          subtipos                                               e hipoglucemia\n  0                       Glucógeno sintasa              Hígado                  Hipoglucemia\n  GLUCOGENOSIS MUSCULARES\n  V                       Miofosforilasa                 Músculo                 Mialgia, intolerancia al ejercicio y\n  Mc Ardle                                                                       debilidad\n  VII                     Fosfofructocinasa y            Músculo, eritrocitos    Miopatía, anemia hemolítica, afectación\n  Tarui                   variantes                                              multisistémica (convulsiones,\n                                                                                 cardiopatía)\n  -                       Fosfoglicerato cinasa          Músculo, eritrocitos,   Intolerancia al ejercicio, anemia\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}